Earnings call Neurocrine Biosciences reports strong Q3 growth, plans ahead
| DBMYX Fund | USD 30.40 0.25 0.83% |
Slightly above 50% of Dreyfus/the Boston's investors are presently thinking to get in. The analysis of overall sentiment of trading Dreyfusthe Boston Pany mutual fund suggests that some investors are interested at this time. Dreyfus/the Boston's investing sentiment can be driven by a variety of factors including economic data, Dreyfus/the Boston's earnings reports, geopolitical events, and overall market trends.
Dreyfus/the |
Earnings call Neurocrine Biosciences reports strong Q3 growth, plans ahead
Read at investing.com
 |
Dreyfus/the Boston Fundamental Analysis
We analyze Dreyfus/the Boston's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dreyfus/the Boston using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dreyfus/the Boston based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
One Year Return
One Year Return Comparative Analysis
Dreyfusthe Boston is currently under evaluation in one year return among similar funds. One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading.
Dreyfusthe Boston Pany Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dreyfus/the Boston mutual fund to make a market-neutral strategy. Peer analysis of Dreyfus/the Boston could also be used in its relative valuation, which is a method of valuing Dreyfus/the Boston by comparing valuation metrics with similar companies.
Peers
Dreyfus/the Boston Related Equities
| ASCLX | Ab Select | 0.14 | ||||
| TSDUX | Ultra-short Term | 0.10 | ||||
| CDICX | Calvert Short | 0.06 | ||||
| VISTX | Vanguard Institutional | 0.08 | ||||
| OWSBX | Old Westbury | 0.1 | ||||
| GTLSX | Quantitative | 0.20 |
Other Information on Investing in Dreyfus/the Mutual Fund
Dreyfus/the Boston financial ratios help investors to determine whether Dreyfus/the Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Dreyfus/the with respect to the benefits of owning Dreyfus/the Boston security.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |